OptiNose Corp (OPTN) - Quarterly Sales Growth

Official company branding of Optinose (OPTN)

OptiNose, Inc. (OPTN) is reducing its reliance on the XHANCE spray by expanding access to rhinosinusitis treatment in the US. However, geopolitics and sanctions could disrupt raw material supplies or complicate patent protection. A steady cash flow is based on the sales of ENT drugs. Quarterly growth in sales confirms the business's resilience, and the value of 24.20 shows the latest value of this metric.

OPTN (Optinose) Quarterly Sales Growth Rate history from 07/04/2022 to 05/31/2025

Analytical breakdowns and data insights for company OptiNose Inc (OPTN)

- current quotes and average value forecast:
Fundamental company analysis:OptiNose Inc (OPTN)
Mass-produced product of OptiNose

Professional managers utilize fundamental metrics to filter assets, assessing business expansion rates through the percentage change in current quarter revenue compared to the same period last year. For OptiNose, Inc. (OPTN), whose developments are protected by a sovereign product cycle, the quarterly revenue growth rate confirms the resilience of demand for innovative medicine, allowing investors to differentiate real organic growth from market noise.

Main competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Sales Growth Theravance Biopharma, Inc. (TBPH)|Quarterly Sales Growth AQST (Aquestive Pharma)|SCPH - Quarterly Revenue Growth Rate|Quarterly Revenue Growth TECX (Tectonic Therapeutic, Inc.)|TNXP - Quarterly Sales Growth|China SXT Pharmaceuticals, Inc. - Quarterly Revenue Growth|EPRX - Quarterly Revenue Growth|BHST: Quarterly Revenue Growth|Quarterly Revenue Growth Rate eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Quarterly Revenue Growth|Sales Growth QoQ ENTX (Entera Bio)|Revenue Growth QoQ MindWalk (HYFT)|Quarterly Revenue Growth ABVC BioPharma, Inc. (ABVC)|Revenue Growth QoQ Cumberland Corp CPIX|QNTM - Quarterly Sales Growth|FGEN - Revenue Growth QoQ|TELO - Quarterly Revenue Growth|Rani Therapeutics Inc (RANI) - Revenue Growth QoQ|Sales Growth QoQ SNYR|Revenue Growth QoQ Rallybio Corp|Revenue Growth QoQ LEXX|Quarterly Revenue Growth PULM|PTHL: Revenue Dynamics QoQ|Quarterly Revenue Growth APM (Aptorum Group Ltd)|LYRA - Quarterly Sales Growth|Impact BioMedical Inc - Quarterly Revenue Growth|Revenue Dynamics QoQ TNFA|YCBD (cbdmd.com) - Quarterly Sales Growth|painreform.com - Quarterly Revenue Increase|Quarterly Sales Growth CYTO|Revenue Growth QoQ LIPO|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)